NFKB1 and cystic fibrosis: In CF, the consequence of F508del-CFTR mutation in lung epithelial cells is well documented in enhanced activation of NF-κB signaling, which is associated with the CFTR dysfunction i.e., incompetence of F508del-CFTR to reach cell surface68–70.